Human RIOK-3 is over-expressed in cancer cells [11-13] and interacts with caspase-10 to down-regulate NF-κB signaling by competing with receptor-interacting protein 1 (RIP1) and NF-κB-inducing kinase (NIK) [14]. This evidence concerns the gene RIPK1 and cancer.